Evidence map›Paper›PMID 34035368›Full record

ArticleScientific reports2021

Kinship of conditionally immortalized cells derived from fetal bone to human bone-derived mesenchymal stroma cells.

S Marozin, B Simon-Nobbe, S Irausek, L W K Chung, G Lepperdinger

Open access · goldAbstract readComparative Study
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Analysis of theCells · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

S Marozin *Department of Biosciences, University of Salzburg, Hellbrunnerstr. 34, 5020, Salzburg, Austria. sabrina.marozin@sbg.ac.at.
B Simon-Nobbe *Department of Biosciences, University of Salzburg, Hellbrunnerstr. 34, 5020, Salzburg, Austria.
S IrausekDepartment of Biosciences, University of Salzburg, Hellbrunnerstr. 34, 5020, Salzburg, Austria.
L W K ChungCedars-Sinai Medical Center, Dept. of Medicine, 8700 Beverly Blvd b106, Los Angeles, CA, 90048, USA.
G LepperdingerDepartment of Biosciences, University of Salzburg, Hellbrunnerstr. 34, 5020, Salzburg, Austria.
University of Salzburg · ATCedars-Sinai Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The human fetal osteoblast cell line (hFOB 1.19) has been proposed as an accessible experimental model for study of osteoblast biology relating to drug development and biomaterial engineering. For their multilineage differentiation potential, hFOB has been compared to human mesenchymal progenitor cells and used to investigate bone-metabolism in vitro. Hereby, we studied whether and to what extent the conditionally immortalized cell line hFOB 1.19 can serve as a surrogate model for bone-marrow derived mesenchymal stromal cells (bmMSC). hFOB indeed exhibit specific characteristics reminiscent of bmMSC, as colony formation, migration capacity and the propensity to grow as multicellular aggregates. After prolonged culture, in contrast to the expected effect of immortalization, hFOB acquired a delayed growth rate. In close resemblance to bmMSC at increasing passages, also hFOB showed morphological abnormalities, enlargement and finally reduced proliferation rates together with enhanced expression of the cell cycle inhibitors p21 and p16. hFOB not only have the ability to undergo multilineage differentiation but portray several important aspects of human bone marrow mesenchymal stromal cells. Superior to primary MSC and osteoblasts, hFOB enabled the generation of continuous cell lines. These provide an advanced basis for investigating age-related dysfunctions of MSCs in an in vitro 3D-stem cell microenvironment.

Indexed as

Bone and BonesCell Culture TechniquesCell DifferentiationCell LineCell MovementCell ProliferationCulture Media, ConditionedCyclin-Dependent Kinase Inhibitor p16Cyclin-Dependent Kinase Inhibitor p21HumansMesenchymal Stem CellsOsteoblastsCDKN1A protein, humanCDKN2A protein, humanCulture Media, ConditionedCyclin-Dependent Kinase Inhibitor p16Cyclin-Dependent Kinase Inhibitor p21

Identifiers

PMID34035368
PMCPMC8149839
OpenAlexW3164865365

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.